Business Wire

Introducing: ASICS GEL-RESOLUTION™8: High-tech Tennis Shoe for Baseline Players

Share

In the latest evolution of the iconic GEL-RESOLUTION tennis shoe series, ASICS has announced the launch of the new GEL-RESOLUTION 8 model. Loaded with advanced technology underpinned by the human-centric science approach of the ASICS Institute of Sports Science (ISS), the GEL-RESOLUTION 8 shoe is designed with the modern baseline player in mind, giving players the edge they need to win long, powerful rallies from the back of the court.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191201005093/en/

ASICS GEL-RESOLUTION 8 (Photo: Business Wire)

ASICS GEL-RESOLUTION 8 (Photo: Business Wire)

Developed with the input of eight-time ATP singles tour titlist, and current top 10 player, Gaël Monfils, the GEL-RESOLUTION 8 boasts unique ASICS features such as DYNAWALL™ technology, which ensures superior balance of stability and flexibility; DYNAWRAP™ technology, a system of panels that cradle the foot and use the players own momentum to maintain an excellent fit, and a unique outsole design that maximizes contact area in zones that are crucial to braking, reducing friction when sliding.

According to testing at the Institute of Sport Science, the GEL-RESOLUTION 8 delivers 7.2% more dynamic braking force than its predecessor, GEL-RESOLUTION 7- enabling quicker recovery and surefooted returns from the baseline.

“Shoes are very important, I need to trust them and the first thing I look for in tennis shoes is stability – stability and comfort,” says Gaël Monfils. “It’s no secret that I am an extreme mover on the court, and with these shoes I feel confident and balanced to return any shot. I've been putting GEL-RESOLUTION 8 to the test and the stability and grip is unreal, no doubt ASICS has exceeded my expectations again.”

Tatsuya Ishikawa, Lead Researcher with the ISS Footwear Function Development Team added, “Ultimately the GEL-RESOLUTION 8 tennis shoe reflects ASICS’ commitment to understanding the mechanics of tennis. In contrast to running, which is principally about moving in straight lines, tennis involves a lot of different movements. It’s our job to focus on those, and every new release takes that to the next level. We’ve been selling tennis shoes since 1952, and as playing styles have evolved and become more physical––from the pro ranks right down to youth tennis––our shoes have adapted to meet those requirements.”

“With tennis shoes, the ultimate goal is to give the wearer more time,” adds Isamu Ochi, General Manager of ASICS CPS Footwear Division’s Product Management Department. “That means the time to make that crucial return, prepare for the next shot, seize the upper hand and put your opponent on the back foot. Being able to stop and change direction quickly is vital to that, which is where our new GEL-RESOLUTION™ 8 model comes in.”

GEL-RESOLUTION™ 8 is available now at ASICS’ retail stores and online at ASICS.com.

Follow @ASICStennis or asics.com/tennis for all ASICS latest tennis product and athlete updates.

-ENDS-

About ASICS Corporation: Headquartered in Kobe, Japan, ASICS is a leading designer, manufacturer and retailer of high-performance athletic footwear, apparel and accessories. Founded in 1949 by Kihachiro Onitsuka, the company name is derived from the Latin saying Anima Sana In Corpore Sano (“A Sound Mind in a Sound Body”), and this belief continues to guide the activities of the organization as a whole. ASICS has regional operations in Japan, the Americas, Europe, and Oceania, as well as South, East, and Southeast Asia, distributing products to over 150 countries and regions worldwide. The company also operates the Onitsuka classic footwear and HAGLOFS outdoor brands.

About ASICS ISS: The ASICS Institute of Sport Science (ISS) embodies the corporate vision to “Create Quality Lives through Intelligent Sport Technology.” Maintaining “human-centric science”, the Institute focuses on the analysis of natural movements and actions. Developing and working with unique materials, ISS continues to lead innovation within the industry.

(*According to ISS test; in comparison with GEL-RESOLUTION™ 7)

Contact information

Lindsay Mandeville
PR Manager
ASICS Europe
+31 (0) 625 466 893

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EETPress release

HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop

Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EETPress release

Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities

Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EETPress release

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator

HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EETPress release

HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme

Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EETPress release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w

Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EETPress release

Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom